Ohio State University James Cancer Hospital is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Ohio State University James Cancer Hospital has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Covid-19, Sars-CoV2, Pneumonia.
Sponsors: Ohio State University Comprehensive Cancer Center, Regeneron Pharmaceuticals, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Ohio State University James Cancer Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ohio State University James Cancer Hospital has 4 clinical trials on record, with 3 currently active. Their work covers Covid-19, Sars-CoV2, Pneumonia.
Yes — Ohio State University James Cancer Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.